tiprankstipranks
TipRanksTop Financial ExpertsInsidersMuneer Satter

Muneer Satter Insider Profile

11 Followers
Muneer Satter, Director, Ten Percent Owner at Immunic, holds 10.34M shares in Annexon Biosciences (Ticker: ANNX), holds 16.61M shares in Rein Therapeutics (Ticker: RNTX), holds 5.62M shares in Whitehawk Therapeutics (Ticker: WHWK). Most recently, Muneer Satter Bought ― shares of Annexon Biosciences on May 29, 2026 for an estimated value of $3.32M.
See the Hottest Stocks Based on Insider Trading >
tipranks
Muneer Satter

Muneer Satter
Immunic (IMUX)
Director, Ten Percent Owner

Ranked #84,353 out of 107,686 Corporate Insiders

Profitable Transactions

28%
13 out of 47 Profitable Transactions

Average Return

-5.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$109M
52.74%
23.07%
16.24%
6.09%
1.87% Others
A breakdown of Muneer Satter's holdings
See the Top Stocks by Insiders

Insider Roles

Annexon Biosciences
(ANNX)
Director
Whitehawk Therapeutics
(WHWK)
Director, Ten Percent Owner
Rein Therapeutics
(RNTX)
In connection with its original investment, SMTP h, Director
Eledon Pharmaceuticals
(ELDN)
Ten Percent Owner
+2 other positions
Roles that Muneer Satter holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Immunic
(IMUX)
Rating:Informative Buy
Date:Apr 16, 2014 - Apr 16, 2015
Return:+800.00%
The most profitable trade made by Muneer Satter
See the Latest Stocks Traded by Insiders

Muneer Satter's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMUX
Immunic
Sep 17, 2018
Director, Ten Percent Owner
Informative Sell
4.11M
$0.00
WHWK
Whitehawk Therapeutics
Jan 10, 2019
Director, Ten Percent Owner
Informative Buy
149.95K
$25.24M
RNTX
Rein Therapeutics
Jan 08, 2021
In connection with its original investment, SMTP h, Director
Informative Buy
9.90M
$17.77M
ANNX
Annexon Biosciences
May 29, 2026
Director
Informative Buy
3.32M
$57.71M
AKBA
Akebia Therapeutics
Jul 11, 2017
Director
Informative Buy
15.00M
$2.04M
HTWR
HeartWare International
―
―
―
$41.40M
ELDN
Eledon Pharmaceuticals
Sep 24, 2014
Ten Percent Owner
Informative Buy
2.25M
$6.66M
DLLR
DFC Global
―
―
―
―
List of latest transactions for each holding click on a transaction to see Muneer Satter's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Muneer Satter insider profile FAQ

What is the percentage of profitable transactions made by Muneer Satter?
The percentage of profitable transactions made by Muneer Satter is 28%.
    What is the average return per transaction made by Muneer Satter?
    The average return per transaction made by Muneer Satter is -5.60%.
      What stocks does Muneer Satter hold?
      Muneer Satter holds: IMUX, WHWK, RNTX, ANNX, AKBA, HTWR, ELDN, DLLR stocks.
        What was Muneer Satter’s latest transaction?
        Muneer Satter latest transaction was an Informative Buy of $3.32M.
          What was Muneer Satter's most profitable transaction?
          Muneer Satter’s most profitable transaction was an Informative Buy of IMUX stock on April 16, 2014. The return on the trade was 800.00%.
            What is Muneer Satter's role in Immunic?
            Muneer Satter's role in Immunic is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.